StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Launch

<< Previous

Bullboard Posts

Next >>

Comment by capebretongirlon Mar 19, 2021 2:53pm

128 Views

Post# 32839497

RE:Launch

skiboard09 wrote:
If I were Tripp Monday would be a good time to launch this.

Waiting meer days or day of record date seems foolish as if he misses this promise shareholders will not be happy.

I don't care if he comes out and says it's due to all the covid tests. I mean we never get info regarding how many tests we are doing a day. In the prospectus I believe goal was upwards of 3k a day? Maybe I'm wrong. But that alone would be a good NR stating we have achieved our goal/forecast/capacity.

anyways not many days left to launch. Beginning of week makes more sense then the end. Let's go Tripp

I would like to see it released when we are GREEN so as to contunue the momentum.